Telix Pharmaceuticals | TLX - Beban Bunga Utang

Keuangan

AUD

AUD 1.36B

AUD 141.87M

Biaya Penjualan

AUD 245.71M

AUD 488.02M

Kewajiban Lancar

AUD 242.34M

AUD 467.11M

AUD 46.36M

AUD 76.49M

Eps Laba Per Saham

AUD 0.1

Modal Dan Cadangan

AUD 408.17M

Laba Kotor Pada Penjualan

AUD 260.35M

Beban Bunga Utang

AUD 19.39M

Pendapatan Bunga

AUD 1.37M

AUD 564.44M

Kapitalisasi Pasar

AUD 5.02B

Batas Pemasukan

AUD 38.33M

Biaya Operasional

AUD 430.99M

Laba Operasional

AUD 46.36M

Modal Saham Biasa

AUD 339.79M

Pe Harga Untuk Laba

223.36

Laba Sebelum Pajak

AUD 76.73M

Pendapatan Penjualan

AUD 477.35M

Beban Penjualan Dan Administrasi

AUD 107.02M

AUD 37.08M

Kreditur Perdagangan

AUD 168.97M

Debitur Perdagangan

AUD 170.39M

	Beban Bunga Utang	Perubahan		Tanggal
Cochlear	AUD 6.3M		3.65M	2025-12
CSL	USD 215M		111M	2025-12
Integral Diagnostics	AUD 5.34M		6.08M	2024-06
Mayne Pharma	AUD 1.2M		50K	2024-06
Medical Developments International	AUD 18K		3K	2025-06
Mesoblast	USD 11.29M		461K	2025-12
Neuren Pharmaceuticals	AUD 0		0	2024-06
Paradigm Biopharmaceuticals	AUD 1000		3K	2025-06
Polynovo	AUD 506K		130K	2025-06
PYC Therapeutics	AUD 17K		11K	2025-06
Ramsay Health Care	AUD 300.6M		15.5M	2025-12
ResMed	USD 775K		886K	2024-12
Sonic Healthcare	AUD 86.91M		43.94M	2024-12